Trade Pfizer ^PFE

Pfizer CEO on primary care, GLP-1 outlook and innovation timeline

Casdatifan 在肾癌中表现出与 HIF-2α 生物学相关的持久疗效

Rigel CMO Lisa Rojkjaer Retires, Alison Hannah Appointed As New CMO

IFM Investors Pty Ltd Grows Stake in Pfizer Inc. $PFE

Exclusive | Ex-NYT journo Alex Berenson tells 'Pod Force One' more Biden COVID records are coming

Safety and immunogenicity of concomitant quadrivalent meningococcus ACYW-TT and meningococcus group B vaccines

AI-assisted image analysis of tumor-infiltrating lymphocytes as a prognostic marker in chemotherapy-naïve luminal breast cancer

Nike earnings crushed Wall Street's estimates - but here's the catch | Morningstar

Nike earnings crushed Wall Street's estimates, but there's a catch | Morningstar

3 Dirt-Cheap Stocks Under $45 Built to Outperform in a Volatile Market

Wall Street Walked Away From This Powerhouse Stock, But I Am Buying It on Repeat

Pfizer (NYSE:PFE) Shares Down 1.2% - What's Next? - Daily Political

Promising Pharmaceutical Stocks To Research - June 30th - Stock Observer

Pfizer Inc. $PFE Shares Sold by Forum Financial Management LP

Lansforsakringar Fondforvaltning AB publ Has $88.70 Million Stake in Pfizer Inc. $PFE - Markets Daily

Lansforsakringar Fondforvaltning AB publ Has $88.70 Million Stock Position in Pfizer Inc. $PFE - Zolmax

Pharma-Funded Campaign Silenced Online Vaccine Dissent, Documents Reveal - NaturalNews.com

Ozempic Sat Unused for Decades

Improving neoadjuvant and perioperative therapy in non-small-cell lung cancer

Will FDA's New IBRANCE (palbociclib) Maintenance Approval Reshape Pfizer's (PFE) Oncology Narrative?

Tailor Your Digital Strategy to Reach Every Customer

3 Monster Stocks to Buy Right Now With Dividend Yields of 5% or More

Pfizer, Innovent GLP-1 drugs pass China insurance preliminary review

A pilot translational study of neoadjuvant fulvestrant plus abemaciclib in women with advanced low-grade serous carcinoma

Beyond EML4: efficacy of targeted therapy in lung cancer patients with rare ALK fusions - a real-world retrospective analysis

China surpassing Europe in Drug Innovation and Development, Pfizer Inc. (PFE) Executive says

Pfizer (PFE) Could Be 13% Undervalued On Mixed Oncology News And CFO Change

Moderna Stock and Healthcare Names Facing the Biggest Regulatory Calls

Pfizer Inc. $PFE Shares Bought by Fort Washington Investment Advisors Inc. OH

Pfizer (NYSE:PFE) Stock Price Up 2.6% - Time to Buy? - Daily Political

Fort Washington Investment Advisors Inc. OH Increases Stock Holdings in Pfizer Inc. $PFE - Daily Political

Pfizer (PFE) Dismissed From Generic Drug Price Fixing Lawsuit

The Market Just Pulled Back Again. These 3 Blue Chips Are the Ones to Buy.

Pfizer (PFE) Wins EU Approval For Keytruda And Padcev In Bladder Cancer

Welch Group LLC Buys 165,513 Shares of Pfizer Inc. $PFE - Daily Political

Econ Financial Services Corp Has $4.15 Million Position in Pfizer Inc. $PFE - Daily Political

Pfizer (NYSE:PFE) Shares Up 2.6% - Still a Buy? - Zolmax

Pfizer (NYSE:PFE) Trading Up 2.6% - Still a Buy?

Moderna Is Up 13% Today: Is It Outperforming Other Vaccine Stocks Like Merck and Pfizer?

Weekly Buzz: IONS, MRK Get FDA Approvals; ACHV Gets CRL; ADCT Cuts Jobs; TECH Acquired

CFOs On the Move: Week ending June 26

Profits rise by a quarter at Irish unit of Jacobs Engineering

Is NIKE's (NKE) New CFO Hire a Turning Point for Its Turnaround Strategy?

OLD National Bancorp IN Buys 55,288 Shares of Pfizer Inc. $PFE

Pfizer Inc. $PFE Shares Sold by Meyer Handelman Co. - Daily Political

301,402 Shares in Pfizer Inc. $PFE Purchased by Contravisory Investment Management Inc. - Daily Political

Cliramitug for depletion of cardiac amyloid transthyretin: long-term follow-up of the NI006-101 trial

Pfizer (NYSE:PFE) Trading Down 1.7% - Should You Sell?

Pfizer's US Paxlovid patent fight turns on a single error

FDA Clears IBRANCE Combination For A New HR+/HER2+ Advanced Or Metastatic Breast Cancer Indication

Pfizer (PFE) Is Down 7.3% After Mixed Oncology Updates Reshape Its Long-Term Pipeline Narrative

Novel approaches in depression treatment: from rapid-acting antidepressants to personalized interventions

Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial

Pfizer (NYSE:PFE) Shares Down 2.7% - What's Next?

Promising Dividend Stocks To Add to Your Watchlist - June 24th - Markets Daily

Pfizer Declares Third-Quarter 2026 Dividend

FDA Approves Expanded Use of Pfizer's (PFE) Ibrance for Breast Cancer Treatment

Pfizer (PFE) Reaffirms FY 2026 Outlook Amid Leadership Change

Pfizer Freed From US States' Drug Price-Fixing Conspiracy Claims

Nike names former Pfizer CFO David Denton as finance chief

Top Pharmaceutical Stocks To Watch Now - June 24th - Stock Observer

Merck (MRK) Secures EU Approval for Keytruda in Bladder Cancer Treatment

Nike hires Pfizer's David Denton to take over for departing CFO

Women say contraceptive jab complications 'life-changing' at MSP meeting

European Commission Approves KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as First PD-1 Inhibitor Plus Antibody-Drug Conjugate Regimen for Adults With Cisplatin-Ineligible Resectable Muscle-Invasive Bladder Cancer

Coerente Capital Management Purchases 34,339 Shares of Pfizer Inc. $PFE

Pfizer Inc. $PFE Holdings Decreased by Focused Wealth Management Inc

Dow Jones Top Company Headlines at 11 PM ET: Nike Names Pfizer's Denton as Next CFO | FedEx ... | Morningstar

Nike faces more challenges after CFO change, Evercore says

China leads in drug innovation over Europe | The Straits Times

Dow Jones Top Company Headlines at 9 PM ET: Nike Names Pfizer's Denton as Next CFO | FedEx ... | Morningstar

Long-term follow-up of the transplant-eligible cohort of the EMN12/HOVON-129 study for primary plasma cell leukemia patients

Risk stratification and relapse pattern in triple-negative breast cancer with pathological complete response after neoadjuvant treatment: the European GAMBIT real-world study

Dow Jones Top Company Headlines at 7 PM ET: Nike Names Pfizer's Denton as Next CFO | FedEx ... | Morningstar

Pfizer (NYSE:PFE) Trading Down 1.3% - Should You Sell? - Markets Daily

Dow Jones Top Company Headlines at 5 PM ET: Nike Names Pfizer's Denton as Next CFO | FedEx ... | Morningstar

Nike Names Pfizer's Denton as Next CFO - Update | Morningstar

Nike Names Pfizer's Denton as Next CFO | Morningstar

Pfizer (PFE) Options Show Bearish Sentiment Amid Price Drop

CEO Albert Bourla's Take on Pfizer Inc. (PFE)

Forget Novo Nordisk. Pfizer's Obesity Pipeline Is Coming, and It Pays You 6.8% While You Wait

Pfizer (NYSE:PFE) Stock Price Down 1.3% - Here's Why - Stock Observer

China outpacing Europe in drug innovation and development, Pfizer executive says

Pfizer Slides After Lung Cancer Drug Setback

Pfizer Inc. $PFE Position Reduced by Hanson & Doremus Investment Management

Pfizer's Sigvotatug Vedotin Misses Primary Overall Survival Endpoint In Phase 3 NSCLC Study

Innovent-Pfizer deal makes joint development, commercialization pillar in biotech global push - Chinadaily.com.cn

Pfizer's $43-billion Seagen bet hits setback as lung cancer drug fails key trial

Pfizer's Lung Cancer Drug Trial Fails to Boost Survival (2)

Pfizer's Lung Cancer Drug Trial Misses Endpoint | Morningstar

Eli Lilly vs Pfizer: One Owns the Obesity Market Today, The Other Paid to Compete Tomorrow

PFE: Oncology And Obesity Pipeline Progress Will Balance Patent Cliff Risks

Could Pfizer Stock Be Your Ticket to Generational Wealth?